Genmab — Maj 2016
-
Sorry..."Den Fattige". Er lidt bagefter i dag.
-
Eller rettere den kom ind kl. 15,16 i mit newsfeed.
-
ok helge . men så den allerede 9.16
-
AB er i hvert fald gode kudner i mobbe-butikken i dag
-
Her er lidt om Neurosearch, som vi talte om tidligere i dag http://medwatch.dk/Medicinal___Biotek/article8716965.ece?utm_source=Feed&utm_medium=latest
-
Mon ikke A/N er Shaw.
-
holy moly - nogen vil gerne ind/ud
-
luk i 1208
-
JnJs curtain raiser til ASCO Most notably, Phase 3 data for the immunotherapy daratumumab in combination with standard therapy have been selected for inclusion in the Plenary Session on Sunday, June 5th and will be featured in the ASCO Press Program.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind